10 facts from the January 2016 CRISPR patent landscape

Our quarterly CRISPR patent landscape is now available. For this first release in 2016, we haveĀ  included the latest business and technology developments, such as licensing deals information and a fully revisited breakdown of the functional and technical claim coverage. Our genomics expert Dr. Fabien Palazzoli has identified 489 CRISPR patent families out from worlwide patent registers, and systematically reviewed them down to individual claim wording to classify them into our unique, worldwide, independent CRISPR patent database.

In the meanwhile, facts and opinion papers around the Broad-Berkeley USPTO patent interference have been overloading our news monitoring capacity in the past 4 weeks… but that’s just about 2 pioneering families in the whole landscape. Here are 10 new facts out of the latest IPStudies CRISPR patent analytics – 489 CRISPR patent families as of January 2016:

Continue reading

Keynote speech at next Questel seminar, Bern, Feb 11

Our partner Questel is organising a hands-on seminar in Bern on February 11th, illustrated with real case scenarios and user experiences, to help you align innovation with your IP strategy using online solutions.

Our head of biotech analytics, Dr. Fabien Palazzoli, will be giving a keynote speech on the use of the Questel Orbit and Intellixir tools, which have helped us developing since June 2014 the first worlwide independent patent landscape on the biotech revolutionary technology CRISPR.

Continue reading